期刊文献+

促性腺激素用药前垂体降调节时间对妊娠结局的影响 被引量:7

Influence of days of downregulation on pregnancy outcomes before gonadotrophin therapy
下载PDF
导出
摘要 目的:探讨促性腺激素(Gn)用药前最佳降调节时间。方法:将2006年3月至2007年8月在本中心接受体外受精-胚胎移植或卵泡浆内单精子显微注射的不孕患者216例,按照Gn用药前垂体降调节时间的不同分为3组,A组≤10d,B组11~14d,C组≥15d。回顾性分析比较不同垂体降调节时间对获卵数、优质胚胎率、临床妊娠率的影响。结果:3组患者年龄、基础内分泌水平[雌二醇(E2)、卵泡刺激素(FSH)、黄体生成素(LH)、孕激素(P)]、人绒毛膜促性腺激素注射日E2、LH、P水平及内膜厚度没有明显差异(P>0.05);C组Gn用药时间、剂量明显高于A、B组(P<0.05);3组获卵数没有明显差异(P>0.05);优质胚胎率、临床妊娠率A组与C组之间没有明显差异(P>0.05),但B组与A、C组之间差异明显(P<0.05)。结论:Gn用药前垂体降调节时间对妊娠结局有一定的影响,降调节时间≥15d时需增大Gn用量及时间,降调节时间11~14d时可得到较高的优质胚胎率和临床妊娠率。 Objective To investigate the optimal days of downregulation before gonadotrophin (Gn) therapy. Methods 216 infertile females who received IVF or ICSI in our center from March 2006 through August 2007 were divided into group A (≤10d), group B (11 - 14 d), and group C (≥15d) according to days of downregulation before the use of Gn. The effects of days of downregualtion on the number of retrieved oocytes, rate of high quality embryos, and clinical pregnancy rate were retrospectively analyzed. Results There were no significances among the three groups in age, baseline levels of E2, FSH, LH, and P, levels of E2, LH, and P and thickness of the endometrium on the day of hCG injection (P 〉 0.05). The days and dosage of Gn therapy were greater in group C than in groups A and B (P 〈 0.05). The number of retrieved oocytes did not differ significantly among the three groups (P 〉 0.05). The rate of high quality embryos and clinical pregnancy rate differed significantly between group B and group A or C (P 〈 0.05) but not between group A and group C (P 〉 0.05). Conclusions Days of downregulaion has an effect on the pregnancy outcomes before Gn therapy. If days of downregulaion were beyond 15, the dosage and duration of Gn therapy should be increased. A greater rate of high quality embryos and a higher clinical pregnancy rate can be obtained when days of downregulation are between 11 and 14.
出处 《实用医学杂志》 CAS 2008年第9期1530-1532,共3页 The Journal of Practical Medicine
关键词 妊娠结局 促性腺激素释放激素激动剂 垂体降调节天数 体外受精-胚胎移植 超促排卵 长方案垂体降调节 Pregnancy outcome Gonadorelin agonist Days of down-regulation of the pituitary IVF-ET COH Long protocol pituitary suppression
  • 相关文献

参考文献9

  • 1胡咏华,徐键,吴丽萍.不同剂量长效抑那通在体外受精-胚胎移植中的治疗效果观察[J].浙江医学,2006,28(11):892-895. 被引量:5
  • 2龙晓林.辅助生殖技术中的控制性超排卵[J].实用医学杂志,2002,18(3):224-226. 被引量:9
  • 3阳翎,陈辉莲,汤倩倩.国产GnRH-a(丙氨瑞林)在IVF-ET促超排卵中的应用[J].实用预防医学,2005,12(4):908-909. 被引量:4
  • 4Olivennnes F, Taieb J, Fanchin R, et al. The single or dual administration of the gonadotropin-releasing hormone antagonist Cetrorelix in an in vitro fertilization-embryo transfer program [J]. Fertil Steril, 1994,62(3) :468-476.
  • 5Prato L D, Borini A, Coticchio G, et al. Half-dose depot triptorelin in pituitary suppression for multiple ovarian stimulation in assisted reproduction technology: a randomized study [J]. Hum Reprod, 2004, 19(10) :2200-2205.
  • 6Palomba S. Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyoma [J]. Hum Reprod, 2004, 19(6) : 1308-1314.
  • 7赵晓徽,随笑琳.两种剂量达必佳在IVF控制超排卵周期降调节中的应用[J].天津医科大学学报,2003,9(1):36-38. 被引量:4
  • 8Elgendy M, Afnan M, Holder R, et al. Reducing the dose of gonadotrophin-releasing hormone agonist on starting ovarian stimulation: effect on ovarian response and in-vitro fertilization outcome [J]. Hum Reprod, 1998,13(9) :2382-2385.
  • 9Prato L D, Borini A, Trevisi M R, et al. Effect of reduced dose of triptorelin at the start of ovarian stimulation on the outcome of IVF: a randomized study [J]. Hum Reprod, 2001,16(7):1409- 1414.

二级参考文献16

  • 1陈新娜,陈贵安,刘平,张丽珠,乔杰,李美芝.改良GnRH-a长方案在控制性促排卵中的应用[J].中国妇产科临床杂志,2002,3(2):75-77. 被引量:5
  • 2庄广伦,顾正田.Buserelin在体外受精超排卵中的作用及其对排卵前卵泡液的影响[J].中华妇产科杂志,1993,28(1):10-13. 被引量:21
  • 3Gonen Y, Dirnfeld M, Glldman S, et al.Theuse of long-acting gonadotrepin-releasing hormone agonist (GnRH-a;Decapeptyl) and gonadotropins versus short-acting GnRH-a (Buserelin) and gonadotropins before and during ovarian stimulation for in vitro fertilization (IVF) [J].In Vitro Embryo Transf, 1991,8:254-259.
  • 4Devreker F, Govaerts I, Bertrand E, et al. The long-acting gonadotropin-releasing hormone analogues impaired the implantation rate [J].Fertil and Steril, 1996,65:122-126.
  • 5Data T, Salha O, Baillie H, et al. A comparison of three gonadotrophin-releasing hormone analogues in an in-vitro fertilization programme:a prospective randomized study [J]. Hum Reprod, 1999,14:288-293.
  • 6Hsieh Y, Tsai H, Chang C, et al. Comparison of a single half-dose,long-acting form of gonadotropin-releasing hormone analog (GnRH-a) and a short-acting form of GnRH-a for pituitary suppression in acontrolled ovarian hyperstimulation program [J]. Fertil and Steril,2000,73:817-820.
  • 7Weston AM, Zelinski-wooten MB, Hutchison JS. Developmental potential of embryos produced by in-vitro fertilization from gonadotropin-releasing hormone antagonist-treated macaques stimulated with recombinant human follicle stimulating hormonealone orin combination with luterinzing hormone [J]. Hum Repred, 1996,11:608.
  • 8Filicofi M. The role of luteinizing hormone in folliculogenesis and ovulation induction [J]. Fertil Steril, 1999,73:405.
  • 9Janssens RM,Vermeiden J, Lambalk C, et al. Gonadotrophin-relesing hormone agonist dose-dependency of pituitary desensitization during controlled ovarian hyperstimulation in IVF [J]. Hum Reprod, 1998,13:2386-2391.
  • 10Janssens RM, Lambalk C, Vermeiden J, et al. Dose-finding study of triptorelin acetate for prevention of a premature LH surge in IVF: a prospective, randomized, double-blind, placebo-controlled study [J]. Hum Repeod, 2000,15:1333-1340.

共引文献17

同被引文献60

引证文献7

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部